Linked Data API

Show Search Form

Search Results

1134018
registered interest false more like this
date less than 2019-06-24more like thismore than 2019-06-24
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Accelerated Access Collaborative more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, if he will list the (a) criteria and (b) timelines for products to be considered in (i) the current round and (ii) future review rounds of the Accelerated Access Collaborative route. more like this
tabling member constituency Strangford more like this
tabling member printed
Jim Shannon remove filter
uin 268506 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-07-02more like thismore than 2019-07-02
answer text <p>In October 2018, the Accelerated Access Collaborative (AAC) announced it was supporting the uptake of 12 high performing products, with the potential to improve the lives of up to 500,000 patients per year and save the National Health Service £30 million per year in England. All the products currently being supported by the AAC have been recommended by the National Institute for Health and Care Excellence, and therefore evidence on clinical benefits and cost savings were considered as part of the process.</p><p>The AAC board met on 26 June and had a positive discussion about future products and expects to announce further products later this year.</p><p>The AAC will consider the following areas of interest when determining which products to support:</p><p>- evidence of clinical and cost effectiveness;</p><p>- addressing significant unmet need;</p><p>- application to large populations or high budget impact; and</p><p>- enabling a novel mode of action or enabling significant changes to the care pathway.</p><p> </p><p> </p>
answering member constituency Gosport more like this
answering member printed Caroline Dinenage remove filter
question first answered
less than 2019-07-02T16:12:14.213Zmore like thismore than 2019-07-02T16:12:14.213Z
answering member
4008
label Biography information for Caroline Dinenage more like this
tabling member
4131
label Biography information for Jim Shannon more like this
1134019
registered interest false more like this
date less than 2019-06-24more like thismore than 2019-06-24
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Accelerated Access Collaborative more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, how products selected by the Accelerated Access Collaborative will be funded. more like this
tabling member constituency Strangford more like this
tabling member printed
Jim Shannon remove filter
uin 268507 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-07-02more like thismore than 2019-07-02
answer text <p>As announced in the Life Sciences Sector Deal 2, up to £2 million of Pathway Transformation Funding has been made available to support the use and integration of product selected by the Accelerated Access Collaborative (AAC) into every day practice within the National Health Service. In addition, four of the seven technology areas currently receiving AAC support have been selected to be funded by NHS England through the Innovation and Technology Payment programme (ITP). The ITP aims to remove financial and procurement barriers to support the NHS to adopt innovative medical devices, diagnostics, and digital products.</p> more like this
answering member constituency Gosport more like this
answering member printed Caroline Dinenage remove filter
question first answered
less than 2019-07-02T16:07:33.677Zmore like thismore than 2019-07-02T16:07:33.677Z
answering member
4008
label Biography information for Caroline Dinenage more like this
tabling member
4131
label Biography information for Jim Shannon more like this
1134020
registered interest false more like this
date less than 2019-06-24more like thismore than 2019-06-24
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Accelerated Access Collaborative more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, whether all products considered by the Accelerated Access Collaborative will have to be cost-neutral to the NHS. more like this
tabling member constituency Strangford more like this
tabling member printed
Jim Shannon remove filter
uin 268508 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-07-02more like thismore than 2019-07-02
answer text <p>As it continues to drive forward the assessment and uptake of the best products for support, the Accelerated Access Collaborative (AAC) has been empowered to be flexible and pragmatic enough to identify truly game-changing innovations, that may not be cost-neutral in year, but are assessed by the National Institute for Health and Care Excellence to be both clinically and cost-effective. This will allow the AAC to identify products, or classes of products, that are most likely to significantly transform care in the National Health Service.</p> more like this
answering member constituency Gosport more like this
answering member printed Caroline Dinenage remove filter
question first answered
less than 2019-07-02T16:06:04.58Zmore like thismore than 2019-07-02T16:06:04.58Z
answering member
4008
label Biography information for Caroline Dinenage more like this
tabling member
4131
label Biography information for Jim Shannon more like this
1134021
registered interest false more like this
date less than 2019-06-24more like thismore than 2019-06-24
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Accelerated Access Collaborative more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what plans the Accelerated Access Collaborative has to prioritise products which help control hospital-acquired infections. more like this
tabling member constituency Strangford more like this
tabling member printed
Jim Shannon remove filter
uin 268509 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-07-02more like thismore than 2019-07-02
answer text <p>The Accelerated Access Collaborative (AAC) is interested in identifying and supporting strategically important products that will have the biggest impact on patient health outcomes and/or the delivery of NHS services. This may include those which help control hospital-acquired infections.</p><p>The AAC has already had made significant progress towards getting the best innovations to patients quicker and at a better cost for the National Health Service.</p><p>Since 2018, NHS England has been supporting SecurAcath and Plus Sutures, products designed to reduce infection rates, on the Innovation and Technology Payment programme. SecurAcath is a device to secure catheters that reduces the infection risk for patients with a peripherally inserted central catheter and has benefited over 80,000 patients. Seven trusts with higher than 4% surgical site infection rates have adopted Plus Sutures, a triclosan coated suture, with more trusts to be supported this year.</p><p> </p> more like this
answering member constituency Gosport more like this
answering member printed Caroline Dinenage remove filter
question first answered
less than 2019-07-02T16:12:48.417Zmore like thismore than 2019-07-02T16:12:48.417Z
answering member
4008
label Biography information for Caroline Dinenage more like this
tabling member
4131
label Biography information for Jim Shannon more like this
1134022
registered interest false more like this
date less than 2019-06-24more like thismore than 2019-06-24
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Accelerated Access Collaborative more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, how the Accelerated Access Collaborative plans to balance its focus on (a) medicines, (b) diagnostic tools and (c) digital services. more like this
tabling member constituency Strangford more like this
tabling member printed
Jim Shannon remove filter
uin 268510 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-07-02more like thismore than 2019-07-02
answer text <p>There are no restrictions on the type of innovation that can be supported by the Accelerated Access Collaborative (AAC). Medicinal products, therapeutic technologies, devices, diagnostics, and digital technologies are eligible to receive support.</p><p>In October 2018, the AAC announced it was supporting to increased uptake and use of 12 high performing products, which span seven technology areas, in the National Health Service. Of the seven categories selected for support, two are medicines, four are diagnostic tests, and one is a device.</p><p>Further information about the products the AAC are supporting can be found at the following link:</p><p><a href="https://www.nice.org.uk/aac" target="_blank">https://www.nice.org.uk/aac</a></p> more like this
answering member constituency Gosport more like this
answering member printed Caroline Dinenage remove filter
question first answered
less than 2019-07-02T16:06:55.223Zmore like thismore than 2019-07-02T16:06:55.223Z
answering member
4008
label Biography information for Caroline Dinenage more like this
tabling member
4131
label Biography information for Jim Shannon more like this
1137416
registered interest false more like this
date less than 2019-07-08more like thismore than 2019-07-08
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Accelerated Access Collaborative more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, if he will list (a) the criteria and (b) the timelines for products to be considered in (i) the current and (ii) future review rounds of the Accelerated Access Collaborative. more like this
tabling member constituency Strangford more like this
tabling member printed
Jim Shannon remove filter
uin 274540 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-07-15more like thismore than 2019-07-15
answer text <p>In October 2018, the Accelerated Access Collaborative (AAC) announced it was supporting the uptake of 12 high performing products, with the potential to improve the lives of up to 500,000 patients per year and save the National Health Service £30 million per year in England. All the products currently being supported by the AAC have been recommended by the National Institute for Health and Care Excellence, and therefore evidence on clinical benefits and cost savings were considered as part of the process.</p><p>The AAC board met on 26 June and had a positive discussion about future products and expects to announce further products later this year.</p><p>The AAC will consider the following areas of interest when determining which products to support:</p><p>- evidence of clinical and cost effectiveness;</p><p>- addressing significant unmet need;</p><p>- application to large populations or high budget impact; and</p><p>- enabling a novel mode of action or enabling significant changes to the care pathway.</p><p> </p><p> </p><p> </p>
answering member constituency Gosport more like this
answering member printed Caroline Dinenage remove filter
question first answered
less than 2019-07-15T15:23:36.753Zmore like thismore than 2019-07-15T15:23:36.753Z
answering member
4008
label Biography information for Caroline Dinenage more like this
tabling member
4131
label Biography information for Jim Shannon more like this
1137418
registered interest false more like this
date less than 2019-07-08more like thismore than 2019-07-08
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Accelerated Access Collaborative more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what criteria the Accelerated Access Collaborative uses in relation to decision-making on (a) medicines, (b) diagnostic tools and (c) digital services. more like this
tabling member constituency Strangford more like this
tabling member printed
Jim Shannon remove filter
uin 274542 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-07-15more like thismore than 2019-07-15
answer text <p>The Accelerated Access Collaborative (AAC) is interested in supporting the most strategically important products that will have the biggest impact on patient health outcomes and delivery of National Health Service services.</p><p>When selecting products, the AAC will consider the following irrespective of innovation type (i.e. medicines, diagnostic tools, and digital products):</p><p>- evidence of clinical and cost effectiveness;</p><p>- addressing significant unmet need;</p><p>- application to large populations or high budget impact; and</p><p>- enabling a novel mode of action or enabling significant changes to the care pathway.</p><p>Further information is available at the following link:</p><p><a href="https://www.nice.org.uk/aac" target="_blank">https://www.nice.org.uk/aac</a></p><p> </p><p> </p> more like this
answering member constituency Gosport more like this
answering member printed Caroline Dinenage remove filter
question first answered
less than 2019-07-15T15:33:03.587Zmore like thismore than 2019-07-15T15:33:03.587Z
answering member
4008
label Biography information for Caroline Dinenage more like this
tabling member
4131
label Biography information for Jim Shannon more like this
1144596
registered interest false more like this
date less than 2019-09-04more like thismore than 2019-09-04
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Alzheimer's Disease: Diagnosis more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what steps he is taking to improve the early detection of Alzheimer's disease. more like this
tabling member constituency Strangford more like this
tabling member printed
Jim Shannon remove filter
uin 286747 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-09-09more like thismore than 2019-09-09
answer text <p>Alzheimer's disease is the most common type of dementia in the United Kingdom.</p><p>The Challenge on Dementia 2020 sets out the ambition for two thirds of people with dementia to receive a formal diagnosis. This has been achieved and exceeded nationally. Our focus now is on reducing the variation in local diagnosis rates and NHS England have published guidance and put programmes in place to further improve the quality and timeliness of diagnosis across the country.</p><p>For example, the ‘Implementation guide and resource pack for dementia care’ published in July 2017 sets out key recommendations on how services should be configured to provide good quality diagnosis and post-diagnostic care for people with dementia and their carers. It includes key roles and activity in primary care and memory assessment services to facilitate an accurate and timely diagnosis of dementia, while ensuring access to appropriate support following diagnosis. The resource pack is available at the following link:</p><p><a href="https://www.england.nhs.uk/mental-health/dementia/implementation-guide-and-resource-pack-for-dementia-care/" target="_blank">https://www.england.nhs.uk/mental-health/dementia/implementation-guide-and-resource-pack-for-dementia-care/</a></p><p> </p><p> </p>
answering member constituency Gosport more like this
answering member printed Caroline Dinenage remove filter
question first answered
less than 2019-09-09T16:15:34.903Zmore like thismore than 2019-09-09T16:15:34.903Z
answering member
4008
label Biography information for Caroline Dinenage more like this
tabling member
4131
label Biography information for Jim Shannon more like this
1147887
registered interest false more like this
date less than 2019-10-02more like thismore than 2019-10-02
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Cochlear Implants more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, when the new cochlear implant for deafness be available on the NHS. more like this
tabling member constituency Strangford more like this
tabling member printed
Jim Shannon remove filter
uin 293581 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-10-08more like thismore than 2019-10-08
answer text <p>NHS England commissions cochlear implants for patients who fulfil the criteria as described in the recently published he National Institute for Health and Care Excellence report ‘Cochlear implants for children and adults with severe to profound deafness: Technology appraisal guidance’ published on 7 March 2019 at the following link:</p><p><a href="https://www.nice.org.uk/guidance/ta566" target="_blank">https://www.nice.org.uk/guidance/ta566</a></p><p>There are a number of cochlear implant devices currently available. Specific advice about which of the devices currently available meet an individual patients requirements would be provided by a patient’s local specialist cochlear implant centre.</p><p> </p><p> </p><p> </p> more like this
answering member constituency Gosport more like this
answering member printed Caroline Dinenage remove filter
question first answered
less than 2019-10-08T10:55:43.46Zmore like thismore than 2019-10-08T10:55:43.46Z
answering member
4008
label Biography information for Caroline Dinenage more like this
tabling member
4131
label Biography information for Jim Shannon more like this
1132910
registered interest false more like this
date less than 2019-06-18more like thismore than 2019-06-18
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Dementia: Diagnosis more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what steps he is taking to increase the accuracy of dementia diagnoses. more like this
tabling member constituency Strangford more like this
tabling member printed
Jim Shannon remove filter
uin 266210 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-06-26more like thismore than 2019-06-26
answer text <p>The Challenge on Dementia 2020 sets out the ambition for two thirds of people with dementia to receive a formal diagnosis. This has been achieved and exceeded nationally. Our focus now is on reducing the variation in local diagnosis rates and NHS England has published guidance and put programmes in place to further improve the quality and timeliness of diagnosis across the country.</p><p>For example, the ‘Implementation guide and resource pack for dementia care’ published in July 2017 sets out key recommendations on how services should be configured to provide good-quality diagnosis and post-diagnostic care for people with dementia and their carers. It includes key roles and activity in primary care and memory assessment services to facilitate an accurate and timely diagnosis of dementia, while ensuring access to appropriate support following diagnosis. The resource pack is available at the following link:</p><p><a href="https://www.england.nhs.uk/mental-health/dementia/implementation-guide-and-resource-pack-for-dementia-care/" target="_blank">https://www.england.nhs.uk/mental-health/dementia/implementation-guide-and-resource-pack-for-dementia-care/</a></p><p><strong> </strong></p><p><strong> </strong></p>
answering member constituency Gosport more like this
answering member printed Caroline Dinenage remove filter
question first answered
less than 2019-06-26T14:40:04.677Zmore like thismore than 2019-06-26T14:40:04.677Z
answering member
4008
label Biography information for Caroline Dinenage more like this
tabling member
4131
label Biography information for Jim Shannon more like this